ArticleJournal of cancer research and clinical oncology2023

Efficacy of rechallenge immunotherapy after immune monotherapy resistance in patients with advanced non-small cell lung cancer.

Manyi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.